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Background: Transcranial direct current stimulation (tDCS) is investigated to modulate
neuronal function including cognitive neuroscience and neuropsychiatric therapies.
While cases of human stimulation with rudimentary batteries date back more than
200 years, clinical trials with current controlled stimulation were published intermittently
since the 1960s. The modern era of tDCS only started after 1998.
Objectives: To review methods and outcomes of tDCS studies from old literature
(between 1960 and 1998) with intention of providing new insight for ongoing tDCS trials
and development of tDCS protocols especially for the purpose of treatment.
Methods: Articles were identified through a search in PubMed and through the
reference list from its selected articles. We included only non-invasive human studies
that provided controlled direct current and were written in English, French, Spanish or
Portuguese before the year of 1998, the date in which modern stimulation paradigms
were implemented.
Results: Fifteen articles met our criteria. The majority were small-randomized controlled
clinical trials that enrolled a mean of approximately 26 subjects (Phase II studies).
Most of the studies (around 83%) assessed the role of tDCS in the treatment of
psychiatric conditions, in which the main outcomes were measured by means of
behavioral scales and clinical observation, but the diagnostic precision and the quality
of outcome monitoring, including adverse events, were deficient by modern standards.
Compared to modern tDCS dose, the stimulation intensities used (0.1–1 mA)
were lower, however as the electrodes were typically smaller (e.g., 1.26 cm2), the
average electrode current density (0.2 mA/cm2) was approximately 4× higher. The
number of sessions ranged from one to 120 (median 14). Notably, the stimulation
session durations of several minutes to 11 h (median 4.5 h) could markedly exceed
modern tDCS protocols. Twelve studies out of 15 showed positive results. Only mild
side effects were reported, with headache and skin alterations the most common.
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Conclusion: Most of the studies identified were for psychiatric indications, especially
in patients with depression and/or schizophrenia and majority indicated some positive
results. Variability in outcome is noted across trials and within trials across subjects, but
overall results were reported as encouraging, and consistent with modern efforts, given
some responders and mild side effects. The significant difference with modern dose, low
current with smaller electrode size and interestingly much longer stimulation duration
may worth considering.
Keywords: tDCS, electric stimulation therapy, human, brain, review
INTRODUCTION
Transcranial direct current stimulation (tDCS) consists of
applying a weak direct current on the scalp, a portion of which
crosses the skull (Datta et al., 2009) and induces cortical changes
(Fregni and Pascual-Leone, 2007; Nitsche et al., 2008). The
investigation of the application of electricity over the brain
dates back to at least 200 years, when Giovanni Aldini (Zaghi
et al., 2010) recommended galvanism for patients with deafness,
amaurosis and ‘‘insanity’’, reporting good results with this
technique especially when used in patients with ‘‘melancholia’’.
Aldini also used tDCS in patients with symptoms of personality
disorders and supposedly reported complete rehabilitation
following transcranial administration of electric current (Parent,
2004).
These earliest studies used rudimentary batteries and so
were constant voltage, where the resulting current depends
on a variable body resistance. Over the 20th century, direct
voltage continued to be used but most testing involved pulsed
stimulation, starting with basic devices where a mechanical
circuit that intermittently connected and broke the circuit
between the battery and the subject and evolving to modern
current control circuits including Cranial Electrotherapy
Stimulation and its variants (Guleyupoglu et al., 2013). Interest
in direct current stimulation (or tDCS) resurged with the
studies of Priori et al. (1998) and Nitsche and Paulus (2000) that
demonstrated weak direct current could change cortical response
to Transcranial Magnetic Stimulation, thereby indicating that
tDCS could change cortical ‘‘excitability’’. Testing for clinical
and cognitive modification soon followed (Fregni et al., 2005,
2006). Developments and challenges in tDCS research, including
applications in the treatment of neuro-psychiatrics disease since
1998 have been reviewed in detailed elsewhere (Brunoni et al.,
2012).
This historical note aims to explore earlier data on human trial
using current controlled stimulation (tDCS) before 1998 with
the goal of informing ongoing understanding and development
of tDCS protocols. As expected, we found variability in the
quality of trial design, data collection and reporting in these
earlier studies. Nonetheless, many clinical findings are broadly
consistent with modern efforts, including some encouraging
results but also variability across subjects. We also describe
a significant difference in dose with lower current, smaller
electrodes and much longer durations (up to 11 h) than used in
modern tDCS.
METHODS
Literature Search
For our searching methodology, we included articles that:
(a) investigated the clinical effects of transcranial direct current
stimulation; (b) were published before 1998; (c) human
studies; (d) written in English, Spanish, Portuguese or French;
(e) controlled current for stimulation. We also excluded articles
if they were reviews or meta-analysis, as well as studies that
involved invasive procedures or other methods of electrical
stimulation.
To identify relevant studies, we searched PubMed using
the keywords (brain polarization), (transcranial direct current
stimulation) and (electric stimulation therapy) along with (brain).
We also searched the reference list of all selected articles to
identify other relevant articles that we might have missed during
the primary PubMed search. Initially, AP and PS conducted the
search but, if there were any unresolved issue, FF was consulted.
Most of the articles were not available online; therefore they were
retrieved at Francis A. Countway Library of Medicine (Harvard,
Cambridge, MA, USA).
The data was collected using a semi-structured form for each
study. The following variables were extracted: (a) title; (b) year of
publication; (c) Journal; (d) number of participants in the study;
(e) their pre-existing condition; (f) medications; (g) intensity of
the applied current; (h) duration of each session; (i) number
of sessions; (j) total duration of stimulation; (k) position of the
electrodes; (l) electrode size; (m) the strategy of stimulation;
(n) clinical effects; (o) side effects; (p) trial design; (q) conclusion;
and (r) main outcome. Some of these data were shown in
Table 1. Because we only found 15 articles fulfilling the inclusion
criteria, and included articles had with incomplete and variable
reporting details, it was not prudent to conduct quantitative
analysis.
Terminology
For the purpose of this study we combine typical terminology
used in modern tDCS with literature with conventions in
classic literature. tDCS always requires a positive (anode) and
negative (cathode) electrode on the body. The term ‘‘active’’
indicates the electrode which is considered by the investigator
to exert behavioral effects, presumably by modulating cortex
under the electrodes, while ‘‘return’’ electrode indicate the
counter polarity electrode which is presumed to have no or
less consequential effect. The anode electrode is presumed to
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generate an excitatory influence, while the cathode a local
inhibitory influence. This concept pervades historical to modern
tDCS design, though modern neurophysiology, imaging and
computational modeling suggest that how and which brain
regions are modulated by tDCS is much more complex. One
electrode must always be on the head. In modern literature,
an electrode below the head is ‘‘extra-cephalic’’ and typically
placed on the forearm. In older literature, ‘‘scalp-positive’’ or
‘‘scalp-negative’’ is used to indicate the use of an extra-cephalic
electrode, typically placed on the hand or foot with the anode or
cathode, respectively, on the head. For example, ‘‘scalp-positive’’
is comparable to ‘‘active anode electrode with extra-cephalic
return’’. For all the limitations in this terminology, here we
respect nomenclature as used in the original reports. Electrode
dimensions are assumed to refer to contact area between the
electrolyte (sponge) and skin.
RESULTS
Figure 1 displays the diagram of search strategy and its results.
Table 1 indicates the final selected studies. Given these 15 articles,
the oldest where current was controlled was written in 1964. The
majority of articles were small studies with number of patients
varying from 1 to 107 (mean, 26 subjects). Approximately half
of the studies (8 out of 15) were randomized controlled trials,
but there were also two single blind and five open the studies.
Most of the studies involved patients with psychiatric disorders,
mainly major depression and schizophrenia (Figure 2B). Only
four studies were performed using exclusively healthy subjects.
Eight out of 15 studies were performed in United Kingdom and
United States (Figure 2B). Positive results were obtained in most
of the analyzed studies (Table 1).
FIGURE 1 | Search strategy for inclusion, exclusion criteria of this
study. To identify relevant studies, we searched PubMed using the keywords
(brain stimulation), (transcranial direct current stimulation) ad (electric
stimulation therapy) along with (brain).
tDCS Parameters
The intensity of electric current varied between studies. The
median of most commonly used intensity was 0.33 mA for each
anode; typically ranging from 0.1 mA (Redfearn et al., 1964)
to 0.5 mA (Nias and Shapiro, 1974) for each anode. However,
Lippold and Redfearn (1964) applied 3 mA in one single patient.
The most common electrode montage was: active electrode(s)
above eyebrow and reference electrode in extra-cephalic position
(e.g., leg, hand; Figure 2A). The active electrodes were most
commonly placed in the frontal—especially supraorbital—but
also in occipital areas of the scalp and vertex. Apart from
the leg and arm, other locations for the return electrode were
also used such as the mastoid bone or collarbone. Historically,
the approach of applying a stimulation over orbital fissures
originated from two other failed trials conducted by Lippold
and Redfearn (1964) and trial and error in electrode placement,
current intensity and stimulation duration. They found that
largest modification in mood and alertness would be produced
when anode is placed over an orbital fissure and cathode at an
extra-cephalic location (e.g., leg, thigh or arm). The essential
differences between the two failed trials and the successful one
was location of electrodes, lower applied current with longer
duration of stimulation (Lippold and Redfearn, 1964) which was
used in most of studies on depression afterwards.
Only 8 out of 15 studies specified the precise dimensions of
the electrodes; in those ones the smallest active electrode was of
0.1 cm2 and the smallest reference electrode was of 0.2 cm2. The
reference electrode area was often larger than the active ones,
from approximately 30% (Lifshitz and Harper, 1968) to 50%
bigger (Baker, 1970), but in some cases was the same (Elbert et al.,
1981a). The use of a larger return electrode compared to active
electrode is in line withmodern conventions (Woods et al., 2016),
though even the larger active and return electrodes are smaller
than used in modern tDCS.
Most of studies employed several sessions of stimulation, with
a median of 14 sessions. The quantity of session varied from
one single to 120 sessions. The median of the total duration of
stimulation was 30 h. Redfearn et al. (1964) conducted the longest
study, with 960 h as the total time of stimulation.
The mean duration of session was 4.5 h (4 h and 30 min)
with a maximum of 11 h (Redfearn et al., 1964) of electrical
stimulation. Due to the long duration of stimulation in several
studies, the devices were portable and patients were able to move
around the hospital or go home (Lippold and Redfearn, 1964;
Redfearn et al., 1964; Ramsay and Schlagenhauf, 1966; Baker,
1970). The regimen of sessions varied across articles—daily
sessions or several days interval between sessions. In average,
stimulation protocols consisted of applying 0.33 mA for 6 h
per session that was continued up to 14 days.
In most included studies, stimulation apparatus was made
of low voltage dry batteries in a pack with a potentiometer
manually adjusted to produce a constant current. In a later
study (Elbert et al., 1981b), an optocoupled system driven
by the analog output provided constant current which had a
ramp up period of 6 s to increase current from 0 mA to
0.25 mA. In all the studies, electrodes were metallic, either
pure silver or silver chloride disks covered with saline soaked
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gauze or lint. Electrode contact and current was checked in
pre-arranged times especially in studies with longer duration of
stimulation.
Clinical and Side Effects
Twelve studies reported positive results. With the exception
of Arfai et al. (1970), all other studies with melancholic or
depressive patients showed some positive results using tDCS.
The most common side effects reported were headache and
skin sensitivity. Half of the studies did not mention any side
effects.
DISCUSSION
Across the limited historical use of tDCS between 1960 and 1998,
there was little standardization of electrical parameters of stimuli.
The lack of methodological rigidity on some parameters such
as reference electrode position, number of sessions, the target
area, current strength, electrode size and duration of each session
might explain some contradictory findings between the studies.
There was often limited information on subject inclusion and
recruitment, in one case, not even the place of origin of the study
was apparent (Herjanic and Moss-Herjanic, 1967).
The values of the current intensity used in the selected
historical tDCS trials, from 0.1 mA to 0.5 mA (median 0.33 mA)
for each anode(s), were overall lower than those ones used
contemporarily in clinical trials, which vary between 1–3 mA
(median 2mA; Bikson et al., 2016). Potentially maximum current
was constrained by hardware limitations (battery voltage),
especially with the need for portability (small size and weight)
and long duration operation (hours per session). Smaller
electrodes were used in historical tDCS trials, but this may
have marginal or no effects in resulting brain current density,
compared to the linear loss with reduced current intensity
(Miranda et al., 2009). Nitsche et al. (2008) demonstrated that,
when stimulations durations are limited to several minutes,
an intensity of 0.6 mA is required to induce a significant
change in average cortical excitability detectable by TMS. Total
stimulation charge was determined by the current and time. The
neurophysiological consequence of lower-intensity stimulation
but with longer period (e.g., hours) is unknown. In most cases
included here the total charge applied (e.g., 4.5 h times 0.25 mA
for each anode = 8100 mC1) was above that is used in modern
tDCS (e.g., 2 mA for 20 min = 2400 mC). The side effect profile
of the included historical trials, to the extent they weremonitored
and reported was mild.
Most of the studies placed the active electrode above the
eyebrow and the reference one on the leg, or on the arm. This
position of the active electrode approximates locations used in
modern human trials. However, the ‘‘reference’’ electrode is now
more commonly placed on the head; extra-cephalic ‘‘return’’
electrodes are sometimes used. Modern computational modeling
studies suggest the use of extra-cephalic electrode produce
significant current flow in deep and mid-brain structures
(DaSilva et al., 2011). Indeed, Redfearn et al. (1964) suggested
1Mili-Coulomb (mC).
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FIGURE 2 | Summary of study parameters on human trials using transcranial direct current stimulation (tDCS) in old literature (from 1960 to 1998).
Models of commonly used montages of tDCS in early studies (A); red: anode electrode(s), blue: cathode electrode(s). Total number of subjects in each group of
patients participating in studies using aforementioned montages (B.1) and leading countries conducting tDCS studies in early stage with number of published
articles (B.2).
that highest current density in extra-cephalic stimulation could
be in brainstem and supported it by evidence of respiratory
depression caused by applying 3 mA cathodal stimulation in a
normal subject.
Historical tDCS trials employed from 1 to 120 sessions with
a median of 14 sessions, and a median of 4.5 h (20 min to 11 h)
of electrical stimulation per session, resulting in a total duration
of the trial with a median of 30 h (150 min to 960 h). Currently,
it is known that stimulation duration of 20–30 min is more than
enough to induce cortical excitability chances and consequently
clinical improvements rather than hours of stimulation that
would compromise patient’s compliance in clinical daily practice
(imagine a patient using tDCS for hours at home).
The Use of Outcomes
The Hamilton Depression Rating Scale—HDRS (Hamilton,
1960), recognized as the gold standard in modern depression
trials, although contemporary to the majority of early tDCS
reviewed was not adopted. Rather early tDCS studies favored
clinical outcomes and depression self-rating scales, more
subjective and of difficult comparability. Only one study used the
HDRS (Arfai et al., 1970). Other more objective measures used
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in depression trials were: laboratory changes (norepinephrine,
serotonin, beta-endorphin and cholinesterase) and cardiac
frequency. In the other conditions addressed, also subjective
and objective outcomes assessment was conducted. Among the
validated outcomes, the Benton Visual Retention Test (Benton,
1946) was used to evaluate the improvement in short-term
memory in alcoholic patients. Tests of reaction to light stimuli
were performed within a schizophrenic group of patients. Other
studies took into account laboratory changes in hormone levels,
self-report scales and several clinical outcomes such as remission
of symptoms, improvement in terms of re-hospitalization and/or
further treatment and medical evaluation.
Trial Design
The majority of the retrieved articles consisted of double blind
controlled clinical trials, which is considered as the ‘‘gold
standard’’ for intervention studies. On the other hand, some of
them were inadequately reported, therefore making difficult to
assess their quality. In a few of these studies, the blinding status
was not clearly defined especially in those allocating patients
with major depression. In fact, without an appropriate blinding,
the results might be biased by a decrease of the placebo effect,
as well as an increase of the number of false-positive results
and over-estimate of the magnitude of an association. Another
aspect to take into account is the high electrical density used that
might have precluded blinding process. In most historical trials,
the number of subjects was relativity small (indicating cautious
interpretation of the results), this remains the case in modern
tDCS pilot trials on new indications.
Adverse Effects
It is difficult to draw a reliable evaluation of the side effects
from these works as the majority of articles did not post how
many healthy subjects or patients were affected, and when
multiple intensities were used did not correlate adverse events
with intensity. There were no reports of subjects needing to
terminate a session or receive medical care for injury. In
contemporary tDCS trials, the most common side effects using
standard protocols and montages—all transitory—are a mild
tingling followed by itching and headache (Brunoni et al., 2011).
Autonomic reactions are considered unlikely according to recent
systematic review (Schestatsky et al., 2013). Historical studies
lacked systematic questionnaire searching for adverse events,
which might underestimate detection of occurrence.
Synopsis
In conclusion, we found 15 studies with semi-systematic
approaches before the year of 1998, considered the time point
of contemporary tDCS. For dosage, the use of multi-hour
stimulation session, albeit with modestly reduced current
intensity is a significant deviation from modern protocols. The
use of supra-orbital active electrode(s) with an extra-cephalic
return is another feature in these older studies, though rarely used
in modern tDCS.
It is difficult to draw firm meta-conclusions from the analysis
of the 15-included studies. This is due to lack of information
regarding patient’s diagnosis and stimulation parameters as well
as varied scientific rigor in design study. The most common
type of patients addressed was from the psychiatric field. The
occurrence of unusual adverse events i.e., papules, pustules and
faint, might be related to longer duration of stimuli and higher
density but also other conditions apart from the stimulation
itself, such as stimulus-induced anxiety and unrelated events in
patients.
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